Drug

Didanosine clinical trials

studies test it: 62
open now: 0
in phase 3: 14
first study started: 1990

How each study uses Didanosine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States: 9 Oct 1991 · VIDEX · NDA 020154 (FDA, Drugs@FDA)
European Union: Not in EMA's list of EU-wide authorisations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Didanosine: 52
ddI: 4
Didanosine (ddI): 3
Videx: 2

Studies by the year they started

24 studies that test it; most in 1999 (5)

Studies that test Didanosine, by start year
Year	Studies
1990	1
1997	2
1999	5
2000	2
2001	1
2004	4
2005	4
2006	2
2007	1
2009	2

By phase

A phase 1/2 study counts in both.

Phase 1: 15
Phase 2: 23
Phase 3: 14
Phase 4: 5
No phase: 7

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

HIV Infections: 52
Acquired Immunodeficiency Syndrome: 4
AIDS Dementia Complex: 1
Sarcoma, Kaposi: 1
AIDS-Related Complex: 1
Cytomegalovirus Infections: 1
Tuberculosis: 1

Who runs them

Industry 24 · Other 38

National Institute of Allergy and Infectious Diseases (NIAID) (25) · Bristol-Myers Squibb (12) · National Cancer Institute (NCI) (2) · Triangle Pharmaceuticals (2) · Pharmacia and Upjohn (2) · AJI Pharma USA (2) · Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections (1) · ANRS, Emerging Infectious Diseases (1)

Often tested with

Tested in the same studies.

Zidovudine (19) · Stavudine (18) · Efavirenz (13) · Lamivudine (10) · Hydroxyurea (9) · Nevirapine (7) · Emtricitabine (5) · Delavirdine (4)

Related medicines

As reviewed, each with the page that says it.

One of Reverse transcriptase inhibitors source

Studies

Open first, then newest update. How each study uses Didanosine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 62

See all 62 studies that test Didanosine →

Given beside what is tested · 2 — Didanosine is usual care or a partner of the new treatment

As the comparator · 1 — what is tested is compared with Didanosine

Optimizing Pediatric HIV-1 Treatment in Infants With Prophylactic Exposure to Nevirapine, Nairobi, KenyaTerminatedPhase 3University of WashingtonNCT00427297Written as ddI/ABC/LPV/r (didanosine/abacavir/lopinavir-ritonavir)

Codes

What other systems call Didanosine · ClinicalTrials.gg INT008512

MeSH (NLM) D016049DidanosineConfirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA) K3GDH6OH08DIDANOSINEConfirmed FDA, NLM, Wikidata
RxNorm 3364Confirmed FDA, Wikidata
Wikidata Q422606didanosineConfirmed FDA, NLM, Wikidata
NCI Thesaurus C431DidanosineOne source FDA
DrugBank DB00900One source Wikidata

System	Code	Name there	Checked by
MeSH (NLM)	D016049	Didanosine	Confirmed ClinicalTrials.gov, NLM, Wikidata
UNII (FDA)	K3GDH6OH08	DIDANOSINE	Confirmed FDA, NLM, Wikidata
RxNorm	3364	—	Confirmed FDA, Wikidata
Wikidata	Q422606	didanosine	Confirmed FDA, NLM, Wikidata
NCI Thesaurus	C431	Didanosine	One source FDA
DrugBank	DB00900	—	One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.